
DBS System announced it closed its Series A at CHF 2.5M which included the direct investment of a Swiss pension fund. DBS System produces blood collection devices that leverage advanced microfluidic technology, greatly simplifying and reducing the cost of blood sampling without modifying existing lab analysis workflows. With this investment, DBS System will industrialize its… Read more »